S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
This Company Is Solving A Multi-Billion Dollar Problem! (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
BREAKING: Tiny biotech successfully treats blindness (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Wall Street inches higher toward edge of bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
This Company Is Solving A Multi-Billion Dollar Problem! (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
BREAKING: Tiny biotech successfully treats blindness (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Wall Street inches higher toward edge of bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
This Company Is Solving A Multi-Billion Dollar Problem! (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
BREAKING: Tiny biotech successfully treats blindness (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Wall Street inches higher toward edge of bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
This Company Is Solving A Multi-Billion Dollar Problem! (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
BREAKING: Tiny biotech successfully treats blindness (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Wall Street inches higher toward edge of bull market
TSE:LABS

MediPharm Labs (LABS) Stock Forecast, Price & News

C$0.07
0.00 (0.00%)
(As of 06/6/2023 ET)
Compare
Today's Range
C$0.07
▼
C$0.08
50-Day Range
C$0.07
▼
C$0.10
52-Week Range
C$0.06
▼
C$0.10
Volume
67,972 shs
Average Volume
183,225 shs
Market Capitalization
C$27.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsInsider TradesHeadlinesSocial Media

LABS stock logo

About MediPharm Labs (TSE:LABS) Stock

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Receive LABS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter.

LABS Stock News Headlines

May 22, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp down on Friday (LABS)
May 15, 2023 | msn.com
MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA
June 7, 2023 | UNKNOWN (Ad)
This NASDAQ Stock Is The Amazon Of Medical Supply
This Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More Now
May 15, 2023 | finance.yahoo.com
MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA
April 19, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp up on Tuesday (LABS)
April 17, 2023 | finance.yahoo.com
Market Participants Recognise MediPharm Labs Corp.'s (TSE:LABS) Revenues Pushing Shares 27% Higher
April 15, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp up on Friday (LABS)
April 13, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp flat on Wednesday (LABS)
June 7, 2023 | Behind the Markets (Ad)
[BREAKING] Pentagon to Spend Billions on "Living Missile"
Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!
April 13, 2023 | msn.com
MediPharm to cut ~30% staff amid restructuring
April 10, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp flat on Monday (LABS)
April 8, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp WT flat on Thursday (LABS-WT)
April 7, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp flat on Thursday (LABS)
April 6, 2023 | theglobeandmail.com
Closing Bell: Medipharm Labs Corp WT flat on Friday (LABS-WT)
April 2, 2023 | seekingalpha.com
MediPharm Labs reports Q4 results
March 31, 2023 | finance.yahoo.com
MediPharm Labs Reports Fourth Quarter and Full Year 2022 Results
March 24, 2023 | ca.finance.yahoo.com
Stocks in play: VIVO Cannabis Inc.
March 6, 2023 | finance.yahoo.com
IIROC Trading Halt - LABS.WT
February 21, 2023 | finance.yahoo.com
MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc.
December 22, 2022 | marketwatch.com
MediPharm Labs to Buy Vivo Cannabis
December 22, 2022 | msn.com
MediPharm Labs to acquire VIVO Cannabis in all-equity transaction
November 16, 2022 | finance.yahoo.com
MediPharm Labs Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
October 7, 2022 | ca.finance.yahoo.com
Stocks in play: MediPharm Labs Corp
August 15, 2022 | seekingalpha.com
MediPharm Labs Corp. (MEDIF) CEO David Pidduck on Q2 2022 Results - Earnings Call Transcript
July 13, 2022 | seekingalpha.com
MediPharm Labs enters $6.2M for the sale of Australian facility
July 11, 2022 | finance.yahoo.com
MediPharm Labs Enters into $6.2M Purchase Agreement for the Sale of Australian Facility
June 30, 2022 | finance.yahoo.com
MediPharm Labs Announces Voting Results From the 2022 Annual Meeting of Shareholders
See More Headlines

LABS Price History

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
TSE:LABS
CUSIP
N/A
CIK
N/A
Web
www.medipharmlabs.com
Phone
705 719 7425
Fax
N/A
Employees
190
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-25,610,000.00
Net Margins
-110.97%
Pretax Margin
N/A
Return on Equity
-39.46%
Return on Assets
-19.80%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
5.30
Quick Ratio
3.10

Sales & Book Value

Annual Sales
C$23.08 million
Price / Sales
1.18
Cash Flow
C$0.05 per share
Price / Cash Flow
1.30
Book Value
C$0.19 per share
Price / Book
0.37

Miscellaneous

Outstanding Shares
390,100,000
Free Float
N/A
Market Cap
C$27.31 million
Optionable
Not Optionable
Beta
1.16

Key Executives

  • Mr. Keith Strachan
    Co-Founder & Pres
  • Mr. Greg Hunter
    Chief Financial Officer
  • Mr. David A. Pidduck
    CEO & Director
  • Mr. Patrick McCutcheon
    Founder
  • Mr. Saravan Subramaniam
    VP of Operations & Supply Chain
  • Mr. Geoffrey Marr
    Exec. VP & Gen. Counsel
  • Mr. Brett Moon
    VP of Sales
  • Mr. Kirk Binns
    Exec. VP of Global Accounts
  • Mr. Nigel Dewsbury
    Head of Quality

Key Competitors

View All Competitors













LABS Stock - Frequently Asked Questions

How have LABS shares performed in 2023?

MediPharm Labs' stock was trading at C$0.07 on January 1st, 2023. Since then, LABS stock has increased by 0.0% and is now trading at C$0.07.
View the best growth stocks for 2023 here.

What other stocks do shareholders of MediPharm Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MediPharm Labs investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Village Farms International (VFF), Canopy Growth (WEED), Aphria (APHA), Cresco Labs (CRLBF), HEXO (HEXO), Heat Biologics (HTBX), Absolute Software Co. (ABT.TO) (ABT) and Acasti Pharma (ACST).

What is MediPharm Labs' stock symbol?

MediPharm Labs trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LABS."

How do I buy shares of MediPharm Labs?

Shares of LABS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is MediPharm Labs' stock price today?

One share of LABS stock can currently be purchased for approximately C$0.07.

How much money does MediPharm Labs make?

MediPharm Labs (TSE:LABS) has a market capitalization of C$27.31 million and generates C$23.08 million in revenue each year. The company earns C$-25,610,000.00 in net income (profit) each year or C($0.11) on an earnings per share basis.

How many employees does MediPharm Labs have?

The company employs 190 workers across the globe.

How can I contact MediPharm Labs?

The official website for the company is www.medipharmlabs.com. The company can be reached via phone at 705 719 7425.

This page (TSE:LABS) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -